Vitiligo trials in Canada
5 of 6 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
- Where
- Calgary, Mississauga, Newmarket, Québec, Toronto, Winnipeg
- Age
- 18 years to 99 years
- People
- 210 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07431177 · EU 2025-522301-37-00 - Phase 2Taking peopleA Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo
- Where
- Edmonton, Guelph, Newmarket, Toronto
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Edesa Biotech Inc.
See details and how to joinNCT07889492 - Phase 2Taking peopleA Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
- Where
- Chicoutimi, London, Ottawa, Richmond Hill, Toronto, Verdun
- Age
- 18 years to 75 years
- People
- 66 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07533019 · EU 2025-524726-18-00 - Phase 3Taking peopleRollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Where
- Barrie, Calgary, Cobourg, Edmonton, London, Markham, Mississauga, Peterborough, Québec, Richmond Hill, Saskatoon, Sherwood Park, St. John's, Toronto, Vancouver, Verdun, Waterloo, Winnipeg
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06855498 · EU 2024-520107-12-00 - Phase 3Taking peopleA Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
- Where
- Calgary, Edmonton, Halifax, Mississauga, Montreal, Ottawa, Québec, Saskatoon, St. John's, Toronto, Vancouver, Winnipeg
- Age
- 2 years to 11 years
- People
- 180 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06548360